Robbie Marcus
Stock Analyst at JP Morgan
(3.88)
# 663
Out of 5,090 analysts
175
Total ratings
54.78%
Success rate
8.45%
Average return
Main Sectors:
Stocks Rated by Robbie Marcus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintains: Neutral | $66 → $78 | $83.10 | -6.14% | 7 | Dec 5, 2025 | |
| MDT Medtronic | Maintains: Neutral | $90 → $100 | $102.09 | -2.05% | 12 | Nov 13, 2025 | |
| HTFL HeartFlow | Maintains: Overweight | $36 → $40 | $28.21 | +41.79% | 2 | Nov 13, 2025 | |
| CNMD CONMED | Maintains: Neutral | $58 → $52 | $41.35 | +25.76% | 8 | Nov 6, 2025 | |
| RXST RxSight | Maintains: Underweight | $8 → $9 | $13.00 | -30.77% | 6 | Nov 6, 2025 | |
| ZBH Zimmer Biomet Holdings | Downgrades: Neutral | $115 → $100 | $94.32 | +6.02% | 7 | Nov 6, 2025 | |
| CBLL CeriBell | Maintains: Overweight | $21 → $17 | $19.60 | -13.27% | 2 | Nov 5, 2025 | |
| INSP Inspire Medical Systems | Maintains: Neutral | $110 → $82 | $138.99 | -41.00% | 7 | Nov 4, 2025 | |
| DXCM DexCom | Maintains: Neutral | $90 → $75 | $66.24 | +13.22% | 3 | Oct 31, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Underweight | $12 → $13 | $13.71 | -5.18% | 7 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $90 | $87.41 | +2.96% | 6 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $16 | $17.25 | -7.25% | 3 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $16 | $16.89 | -5.27% | 5 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $15 → $7 | $9.44 | -25.81% | 7 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $120 | $84.44 | +42.12% | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $36 | $18.72 | +92.31% | 17 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $445 | $364.80 | +21.99% | 9 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $575 → $675 | $575.10 | +17.37% | 5 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $12 → $13 | $7.51 | +73.10% | 3 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $110 | $97.91 | +12.35% | 13 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $280 → $330 | $310.75 | +6.19% | 4 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $40 | $40.52 | -1.28% | 5 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $90 | $84.54 | +6.46% | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $53 → $50 | $28.35 | +76.37% | 2 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $8 | $2.74 | +191.97% | 2 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $284 → $250 | $300.34 | -16.76% | 9 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $8 → $7 | $7.00 | - | 13 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $125 → $118 | $125.37 | -5.88% | 5 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $116 → $156 | $180.94 | -13.78% | 2 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $40 | $109.84 | -63.58% | 2 | May 5, 2020 |
The Cooper Companies
Dec 5, 2025
Maintains: Neutral
Price Target: $66 → $78
Current: $83.10
Upside: -6.14%
Medtronic
Nov 13, 2025
Maintains: Neutral
Price Target: $90 → $100
Current: $102.09
Upside: -2.05%
HeartFlow
Nov 13, 2025
Maintains: Overweight
Price Target: $36 → $40
Current: $28.21
Upside: +41.79%
CONMED
Nov 6, 2025
Maintains: Neutral
Price Target: $58 → $52
Current: $41.35
Upside: +25.76%
RxSight
Nov 6, 2025
Maintains: Underweight
Price Target: $8 → $9
Current: $13.00
Upside: -30.77%
Zimmer Biomet Holdings
Nov 6, 2025
Downgrades: Neutral
Price Target: $115 → $100
Current: $94.32
Upside: +6.02%
CeriBell
Nov 5, 2025
Maintains: Overweight
Price Target: $21 → $17
Current: $19.60
Upside: -13.27%
Inspire Medical Systems
Nov 4, 2025
Maintains: Neutral
Price Target: $110 → $82
Current: $138.99
Upside: -41.00%
DexCom
Oct 31, 2025
Maintains: Neutral
Price Target: $90 → $75
Current: $66.24
Upside: +13.22%
Integra LifeSciences Holdings
Oct 31, 2025
Maintains: Underweight
Price Target: $12 → $13
Current: $13.71
Upside: -5.18%
Oct 31, 2025
Maintains: Neutral
Price Target: $85 → $90
Current: $87.41
Upside: +2.96%
Oct 30, 2025
Maintains: Neutral
Price Target: $13 → $16
Current: $17.25
Upside: -7.25%
May 14, 2025
Maintains: Overweight
Price Target: $14 → $16
Current: $16.89
Upside: -5.27%
May 9, 2025
Downgrades: Underweight
Price Target: $15 → $7
Current: $9.44
Upside: -25.81%
Mar 28, 2025
Initiates: Overweight
Price Target: $120
Current: $84.44
Upside: +42.12%
Feb 21, 2025
Maintains: Neutral
Price Target: $38 → $36
Current: $18.72
Upside: +92.31%
Jan 29, 2025
Maintains: Overweight
Price Target: $420 → $445
Current: $364.80
Upside: +21.99%
Jan 24, 2025
Maintains: Overweight
Price Target: $575 → $675
Current: $575.10
Upside: +17.37%
Dec 17, 2024
Upgrades: Neutral
Price Target: $12 → $13
Current: $7.51
Upside: +73.10%
Dec 16, 2024
Maintains: Overweight
Price Target: $100 → $110
Current: $97.91
Upside: +12.35%
Dec 12, 2024
Maintains: Overweight
Price Target: $280 → $330
Current: $310.75
Upside: +6.19%
Oct 30, 2024
Maintains: Overweight
Price Target: $30 → $40
Current: $40.52
Upside: -1.28%
Sep 9, 2024
Initiates: Neutral
Price Target: $90
Current: $84.54
Upside: +6.46%
Aug 8, 2024
Maintains: Neutral
Price Target: $53 → $50
Current: $28.35
Upside: +76.37%
May 8, 2024
Downgrades: Neutral
Price Target: $15 → $8
Current: $2.74
Upside: +191.97%
Feb 23, 2024
Downgrades: Neutral
Price Target: $284 → $250
Current: $300.34
Upside: -16.76%
Nov 8, 2023
Maintains: Underweight
Price Target: $8 → $7
Current: $7.00
Upside: -
Oct 20, 2022
Maintains: Overweight
Price Target: $125 → $118
Current: $125.37
Upside: -5.88%
Jan 27, 2022
Maintains: Overweight
Price Target: $116 → $156
Current: $180.94
Upside: -13.78%
May 5, 2020
Maintains: Neutral
Price Target: $55 → $40
Current: $109.84
Upside: -63.58%